Prostate specific antigen (PSA) is a glycoprotein produced by prostate cells and though not specific for prostate cancer, elevated PSA values detected by PSA screening was shown to aid in early diagnosis of prostate cancer, thus decrease prostate cancer-related death rates (2,3,4). This evidence concerns the gene KLK3 and prostate carcinoma.